Scholars Central

OtherPublished 23 Jul 2016

The European Union Pediatric legislation: impact on pharmaceutical research in pediatric populations

Authors: Philippe Auby

Clinical Investigation

Volume 4 · Issue 11 · Pages 1013–101

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The first European Paediatric Regulation came into force in the European Union on the 26 January 2007. A few years later, its impact on pharmaceutical research starts to be assessed from different perspectives. Such reflection process is quite valuable as it is anticipated that this regulation will be revised in a few years. Major achievements have occurred and have been acknowledged but there are also divergent opinions, and questions or concerns have been expressed, sometimes leading to interesting controversies. This article will review some background and key features of the European Paediatric Regulation and present, through the examples of pediatric psychopharmacology and oncology, its impact on pharmaceutical research with suggestions for future of pediatric research.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Clinical Investigation.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Investigation
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Philippe Auby”